Voloridge Investment Management, LLC Amylyx Pharmaceuticals, Inc. Transaction History

Voloridge Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.07 - $18.46 $2.37 Million - $3.63 Million	196,478 Added 73.05%	465,445 $6.85 Million
Q3 2023 Nov 14, 2023	BUY	$18.08 - $23.45 $2.79 Million - $3.62 Million	154,338 Added 134.64%	268,967 $4.92 Million
Q2 2023 Aug 14, 2023	SELL	$20.98 - $31.42 $437,139 - $654,667	-20,836 Reduced 15.38%	114,629 $2.47 Million
Q1 2023 May 15, 2023	SELL	$27.71 - $40.93 $4.43 Million - $6.54 Million	-159,802 Reduced 54.12%	135,465 $3.97 Million
Q4 2022 Feb 14, 2023	SELL	$29.75 - $39.26 $2.59 Million - $3.41 Million	-86,945 Reduced 22.75%	295,267 $10.9 Million
Q3 2022 Nov 14, 2022	BUY	$17.15 - $30.92 $6.55 Million - $11.8 Million	382,212 New	382,212 $10.8 Million

127

44.4M

235K

530K

Ticker AMLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,533,200
Market Cap $310M
Description
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.